Natixis Advisors, L.P. Esperion Therapeutics, Inc. Transaction History

Natixis Advisors, L.P.

  • $51.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$11.34 - $21.37 $136,601 - $257,423
-12,046 Closed
0 $0
Q2 2021

Aug 12, 2021
SELL
$19.4 - $28.71 $1,629 - $2,411
-84 Reduced 0.69%
12,046 $255,000
Q1 2021

May 05, 2021
BUY
$25.12 - $36.89 $47,928 - $70,386
1,908 Added 18.67%
12,130 $340,000
Q4 2020

Feb 12, 2021
BUY
$24.2 - $35.76 $247,372 - $365,538
10,222 New
10,222 $266,000

Others Institutions Holding ESPR

# of Institutions
206
Shares Held
128M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $153M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email